Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/17539
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatjana T.
dc.contributor.authorJantaharn P.
dc.contributor.authorKatrun P.
dc.contributor.authorMongkolthanaruk W.
dc.contributor.authorSuwannasai N.
dc.contributor.authorSenawong T.
dc.contributor.authorTontapha S.
dc.contributor.authorAmornkitbumrung V.
dc.contributor.authorMcCloskey S.
dc.date.accessioned2022-03-10T13:17:26Z-
dc.date.available2022-03-10T13:17:26Z-
dc.date.issued2021
dc.identifier.issn14786419
dc.identifier.other2-s2.0-85071024282
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/17539-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85071024282&doi=10.1080%2f14786419.2019.1652292&partnerID=40&md5=38a2f447c8d906b70394b5545a002d26
dc.description.abstractThe ongoing search for anti-cancer agents from microorganisms led to the isolation of four new compounds including 6-ethyl-8-hydroxy-4H-chromen-4-one (1), 6-ethyl-7,8-dihydroxy-4H-chromen-4-one (2), (3S)-3,4-dihydro-8-hydroxy-7-methoxy-3-methylisocoumarin (3) and (3S)-3,4-dihydro-5,7,8-trihydroxy-3-methylisocoumarin (4), together with eleven known compounds (5–15) from Xylaria sp. SWUF09-62 fungus. The chemical structures were deduced from IR, 1D and 2D NMR, and MS data. The absolute configurations of 3 and 4 were determined by ECD experiment. Compounds 2 and 4 indicated possible chemo-prevention and chemo-therapeutic properties, exhibited anti-inflammatory properties by reducing nitric oxide production in LPS-stimulated RAW264.7 cells (IC50 = 1.57 ± 0.25 and 3.02 ± 0.27 μg/mL) and cytotoxicity against HT29 cells (IC50 = 16.46 ± 0.48 and 97.78 ± 7.14 μg/mL). © 2019 Informa UK Limited, trading as Taylor & Francis Group.
dc.subject3,4 dihydro 5,7,8 trihydroxy 3 methylisocoumarin
dc.subject3,4 dihydro 8 hydroxy 7 methoxy 3 methylisocoumarin
dc.subject6 ethyl 7,8 dihydroxy 4h chromen 4 one
dc.subject6 ethyl 8 hydroxy 4h chromen 4 one
dc.subjectantiinflammatory agent
dc.subjectcytotoxic agent
dc.subjectdiclofenac
dc.subjectnitric oxide
dc.subjectunclassified drug
dc.subjectantiinflammatory agent
dc.subjectantineoplastic agent
dc.subjectbiological product
dc.subjectlipopolysaccharide
dc.subjectantiinflammatory activity
dc.subjectArticle
dc.subjectcancer cell
dc.subjectcarbon nuclear magnetic resonance
dc.subjectcell viability
dc.subjectchemical structure
dc.subjectchemoprophylaxis
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectfungus
dc.subjectIC50
dc.subjectinfrared spectroscopy
dc.subjectmacrophage
dc.subjectmass spectrometry
dc.subjectMTT assay
dc.subjectnonhuman
dc.subjectnuclear magnetic resonance
dc.subjectXylariales
dc.subjectanimal
dc.subjectchemistry
dc.subjectHCT 116 cell line
dc.subjectHT-29 cell line
dc.subjecthuman
dc.subjectmetabolism
dc.subjectmouse
dc.subjectnuclear magnetic resonance spectroscopy
dc.subjectpreclinical study
dc.subjectRAW 264.7 cell line
dc.subjectAnimals
dc.subjectAnti-Inflammatory Agents
dc.subjectAntineoplastic Agents
dc.subjectBiological Products
dc.subjectDrug Evaluation, Preclinical
dc.subjectHCT116 Cells
dc.subjectHT29 Cells
dc.subjectHumans
dc.subjectLipopolysaccharides
dc.subjectMagnetic Resonance Spectroscopy
dc.subjectMice
dc.subjectMolecular Structure
dc.subjectNitric Oxide
dc.subjectRAW 264.7 Cells
dc.subjectXylariales
dc.titleAnti-inflammatory and cytotoxic agents from Xylaria sp. SWUF09-62 fungus
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationNatural Product Research. Vol 35, No.12 (2021), p.2010-2019
dc.identifier.doi10.1080/14786419.2019.1652292
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.